Essay Topic Hub

Fda
Essays

773+ paper examples, study guides & outlines

773 papers
1 subject area
UG & Grad levels
Free to browse
About This Topic

The Food and Drug Administration is a federal regulatory agency responsible for overseeing the safety and efficacy of drugs, medical devices, food products, and biological therapies sold in the United States. Students across public administration, health policy, pre-law, business, and life sciences courses write about the FDA because it sits at the intersection of government authority, industry interests, and patient welfare. Its approval processes, enforcement powers, and evolving scope — particularly as new product categories like gene therapy and biotechnology emerge — make it a rich subject for examining how administrative agencies function within the broader regulatory state.

The papers archived on this topic reflect several distinct approaches. Many focus on the FDA's regulatory role in biotechnology, examining how the agency applies existing frameworks to rapidly advancing fields such as gene therapy and genetically modified organisms. Others take an organizational or strategic lens, analyzing the FDA as a complex administrative body with wide-ranging divisions and responsibilities. Policy-focused papers assess the approval process for medical devices and drugs, often arguing that current procedures either move too slowly to serve patients or move too quickly to ensure safety. Some papers approach the topic from a business or environmental-scan perspective, treating FDA regulation as an external force shaping market strategy.

A strong essay on the FDA needs a tightly scoped thesis — arguing a specific position about a particular regulatory process, product category, or policy gap rather than describing the agency in general terms. Evidence drawn from regulatory statutes, approval data, and documented case outcomes carries the most weight. A common pitfall is conflating the FDA's authority over drugs with its separate, distinct framework for medical devices or biologics, which can undermine an otherwise well-developed argument.

773 papers
Sort by:
Research Paper Undergraduate
FDA and Gene Therapy
Ethics can be considered to come from personal values. From both a medical and a business perspective, ethics are the reasons that some news stories should be followed from beginning to end and all in between.
Essay Doctorate
Risk Management Programs Comparison There Are so
There are so many potential risks in hospital and HMO settings because of the nature of healthcare. Hospitals have a ton of regulatory laws to follow that are passed by federal, state, and local legal agencies.
Paper Doctorate
Fluoxetine (Prozac) Since Its Approval for Use
Since its approval for use in the United States by the FDA in 1987, fluoxetine (commonly known as Prozac) has been the subject of great debate. Fluoxetine, now available in generic form, has been proven useful in the…
Paper Masters
Product Recalls and How it Effects the Company
The effects of product recalls on a business have various dimensions. The products carrying potential damage for consumer health are considered vulnerable and they are recalled to save financial loss to the company. The business incurs a loss of reputation in cases of product recalls. The business also faces damage of brand image as well as the brand value in the market. The legal and regulatory issues are also an effect on business carrying potential claims and damages. The degree to which a business is vulnerable to the effects of products recalls is varying to a large extent. The product recall effects are measured in terms of their loss to the credibility and effects on the business standing of a company. Therefore the product recalls are also treated as per the industry requirements.
Paper Undergraduate
Robins and robins: ecological and behavioral characteristics
This paper tackles ethical decision-making in 3 scenarios. The first is the discovery of the inclusion of plastic explosives in some medications manufactured and distributed by Robbins & Robbins through Casings, Inc. The second concerns the right of a Canadian whose son died from a medication manufactured by Robbins & Robbins to sue under the principle of sovereign immunity. And the third are the options open to McFadden, Inc. against FDA's declaratory ruling on tracking bars and what the New York State government's Administrative Procedures Act provides in its case.
Research Paper Doctorate
Project management principles and practices
The project selected for this study is the opening of a new restaurant in New York City. This restaurant will be named: "Home Grown." It will be fashioned after the restaurant-creation in the television program…
Research Paper Doctorate
Mad cow disease and its epidemiological impact
¶ … 80s and the 90s, an unknown but virulent cattle disease, called "Mad Cow," destroyed 180,000 livestock in the United Kingdom and some other European countries and plunged other major cattle-producing nations -…
Paper Doctorate
Human Resources Medical Malpractice Litigations Have Become
Medical malpractice litigations have become very common these days. Perhaps this could be because of the healthcare reform that is characterized with legal and regulatory issues. Confidentiality is an integral part of…
Research Paper Doctorate
External and Internal Environments
This paper is about Glaxo SmithKline, the multinational pharma company. It is a strategy paper, so the focus is on the Five Forces, the SWOT, the external environment and the value chain. All elements are considered, especially the close link between governments and the company and how that affects many of these strategic components.
Research Paper Undergraduate
The future of the pharmaceutical industry in ten years
This paper provides a brief overview of the likely evolution of the pharmaceutical industry in coming decades. Pharmaceutical companies face many challenges, particularly in regards to the fact that so many lucrative drugs are losing their patents, enabling cheaper generics to replace them. Likely future sources of revenue are anti-obesity drugs and diabetes drugs.